Virtu Financial LLC lowered its stake in shares of DaVita Inc. (NYSE:DVA – Free Report) by 70.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,241 shares of the company’s stock after selling 7,765 shares during the period. Virtu Financial LLC’s holdings in DaVita were worth $339,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors have also recently made changes to their positions in the stock. State of Michigan Retirement System raised its holdings in shares of DaVita by 0.6% during the fourth quarter. State of Michigan Retirement System now owns 15,939 shares of the company’s stock valued at $1,670,000 after purchasing an additional 100 shares during the period. Treasurer of the State of North Carolina raised its holdings in shares of DaVita by 0.5% during the third quarter. Treasurer of the State of North Carolina now owns 24,503 shares of the company’s stock valued at $2,316,000 after purchasing an additional 123 shares during the period. PNC Financial Services Group Inc. raised its holdings in shares of DaVita by 1.0% during the third quarter. PNC Financial Services Group Inc. now owns 15,088 shares of the company’s stock valued at $1,426,000 after purchasing an additional 153 shares during the period. Meridian Wealth Management LLC raised its holdings in shares of DaVita by 2.9% during the fourth quarter. Meridian Wealth Management LLC now owns 5,921 shares of the company’s stock valued at $620,000 after purchasing an additional 166 shares during the period. Finally, Daiwa Securities Group Inc. raised its holdings in shares of DaVita by 3.7% during the fourth quarter. Daiwa Securities Group Inc. now owns 4,802 shares of the company’s stock valued at $503,000 after purchasing an additional 171 shares during the period. Institutional investors and hedge funds own 90.12% of the company’s stock.
Insider Buying and Selling at DaVita
In other DaVita news, Director Barbara J. Desoer sold 5,030 shares of the stock in a transaction dated Friday, May 10th. The shares were sold at an average price of $138.81, for a total value of $698,214.30. Following the completion of the sale, the director now owns 10,954 shares in the company, valued at approximately $1,520,524.74. The transaction was disclosed in a document filed with the SEC, which is available at this link. Company insiders own 2.00% of the company’s stock.
Wall Street Analysts Forecast Growth
View Our Latest Report on DaVita
DaVita Trading Up 0.7 %
NYSE:DVA opened at $142.21 on Thursday. The company has a debt-to-equity ratio of 7.95, a quick ratio of 1.37 and a current ratio of 1.43. The firm has a market cap of $12.47 billion, a price-to-earnings ratio of 16.16, a price-to-earnings-growth ratio of 1.08 and a beta of 0.96. DaVita Inc. has a 52 week low of $71.51 and a 52 week high of $147.93. The firm has a 50-day moving average price of $137.96 and a two-hundred day moving average price of $125.02.
DaVita (NYSE:DVA – Get Free Report) last posted its quarterly earnings data on Thursday, May 2nd. The company reported $2.38 EPS for the quarter, beating the consensus estimate of $1.95 by $0.43. The firm had revenue of $3.07 billion during the quarter, compared to analyst estimates of $3.03 billion. DaVita had a net margin of 6.61% and a return on equity of 68.52%. The company’s revenue for the quarter was up 6.9% on a year-over-year basis. During the same quarter last year, the business posted $1.58 EPS. On average, equities analysts expect that DaVita Inc. will post 9.62 earnings per share for the current fiscal year.
About DaVita
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Featured Stories
- Five stocks we like better than DaVita
- Consumer Discretionary Stocks Explained
- Outlook Therapeutics: Analysts Forecast Over 500% Stock Upside
- What is the Dogs of the Dow Strategy? Overview and Examples
- Campbell Soup Co. Targets Fiscal Q4 Stock Recovery
- Upcoming IPO Stock Lockup Period, Explained
- Zebra Analysts Upgrade Stock, Forecasting Major Reversal
Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DaVita Inc. (NYSE:DVA – Free Report).
Receive News & Ratings for DaVita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita and related companies with MarketBeat.com's FREE daily email newsletter.